🤝 Turbine Launches Collaboration with AstraZeneca, Leveraging Turbine’s Virtual Disease Models to Rationalize ADC Discovery

SIMULATE EXPERIMENTS IN TURBINE'S VIRTUAL LAB

How does it work? Try our Virtual Lab

RUN UNBIASED, HYPOTHESIS-FREE EXPERIMENTS
IN OUR VIRTUAL LAB

Simulations let you design more experiments to get a comprehensive answer

50M / day

Simulate millions of experiments in hours

Simulations are a mechanism engine, showing why something occurs

1.5x SUCCESS

Mechanistic hypotheses increase the likelihood of validation

Simulations base every decision on evidence, boosting efficiency and probability of success

2x faster

Timeline halved from scientific question to starting validation

WE HELP PARTNERS MAKE THE RIGHT DECISIONS, REPEATEDLY

TARGET
DISCOVERY

COMBINATION
DESIGN

ADC
POSITIONING

BIOMARKER
SELECTION

CLINICAL
POSITIONING

INDICATION
EXPANSION

TARGET
DISCOVERY

COMBINATION
DESIGN

ADC
POSITIONING

BIOMARKER
SELECTION

CLINICAL
POSITIONING

INDICATION
EXPANSION

Our virtual lab adapts to your needs,
from self-serve to workflow integration

vLab Core

Simulate experiments on public and Turbine's proprietary datasets

1400 oncology cell lines

1200 payloads, drugs and drug-like molecules KO alterations across 8500+ genes

Robust interpretation toolkit for practical filtering and analysis of in silico results

vLab Custom

In silico predictions leveraging your proprietary datasets and Turbine expertise

Add your sample library

Add your drug(s)

Interpretation services

vLab Collaborate

Simulate experiments on virtual endogenous disease models to enhance R&D decision-making across your portfolio

Single or multi-cell samples of most endogenous diseases

Any relevant chemical or biological therapies

Simulations platform adapted to your use case, enabling collaborative analysis and interpretation of results

Wet lab-in-the-loop

In silico predictions are validated in the wet lab and resulting data is incorporated into the Virtual Lab to improve simulation predictivity

Available in turbine’s virtual lab

ADC SIMULATION
SUITE

TARGET ID
SUITE

SIMULATE ANY ENDOGENOUS DISEASE

DAVID M. RUBIN _PhD

Managing Director of MSD Global Health Innovation Fund

“We believe Turbine’s Simulated Cell has the potential to transform key aspects of the oncology drug discovery and development process, providing insight at scale that will shed light on even the most challenging biological mechanisms.”

SEISHI KATSUMATA

Corporate Officer / Executive Director, Discovery & Research of Ono Pharmaceutical

"Turbine has provided multiple targets that have first-in-class potential, along with the biology-driven insights necessary to rapidly validate this potential."

TOM LOUNIBOS

Global Managing Director of Accenture Ventures

"Turbine’s AI-based platform has clearly demonstrated the ability to unlock high-quality biological insights for our clients across the biopharma industry."